mapping the effectiveness and risks of glp 1 GLP-1 receptor agonists Comparative effectiveness of GLP-1 receptor

Aims/hypothesis Regulators worldwide are reviewing safety data on glucagon-like peptide-1 receptor agonists (GLP-1RA), following reports by the Icelandic Medicines Agency in July 2023 of suicidal ideation and self-injury (SIS) in individuals taking liraglutide and semaglutide

Doing everything right and not seeing results

Important Safety Information for GLP-1 Medications

Research that includes diverse populations, especially women over 40

Methods Databases were searched for randomized controlled trials (RCTs), casecontrol, cohort and observational studies involving use of GLP1RA in the intervention arm post-bariatric surgery

ENHANCED ABSORPTION WITH TURMERIC & BIOPERINE: Turmerics curcumin works synergistically with BioPerine to improve nutrient bioavailability, ensuring maximum benefit from every capsule